[Clinical observation of the inthal treatment of bronchial asthma].
The results are reported from the long-term clinical observation on inthal effect in the treatment of 57 patients with various forms of bronchial asthma--atopic (18 patients), infectious--allergic (14 patients), mixed (25 patients). The most pronounced clinical improvement was observed in the patients with atopic bronchial asthma: 66.63 per cent with excellent effect, 11.11 per cent with good effect, 5.56 per cent with poor effect and 16.63 per cent--no effect. A good effect on the clinical symptomatics was observed also in the patients with mixed bronchial asthma: 40 per cent--with excellent effect, 28 per cent--good effect, 12--poor and 20 per cent--no change. The effect of the drug in patients with infectious-allergic bronchial asthma was rather unpretending: 28.58 per cent--excellent, 14.29 per cent--good, 12 per cent--poor and 25.71 per cent--no effect. Corticosteroid dependence was recorded in 46.42 per cent of the patients. The effect of the drug was discussed in connection with bronchial asthma type, graviy of the course and concomitant treatment.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents; D004205:Cromolyn Sodium
Klinichno nabliudenie vurkhu lechenieto na bolni ot bronkhialna astma s intal.